In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Otsuka Holdings Co., Ltd.

http://www.otsuka.com/en/

Latest From Otsuka Holdings Co., Ltd.

Deerfield Management On Fund Building, Philanthropy, And Optimism For The Future

Andrew ElBardissi, partner on Deerfield Management’s medical technologies team, spoke to In Vivo sister publication Medtech Insight about the fund’s investment strategy, the changing face of medtech, and how investment in the life sciences sector will continue to change post-COVID.

Financing Deals

Chinese Biotechs Feel Chill Wind Of Hesitant Investors

Large or small, Chinese biotechs are receiving the cold shoulder from some investors amid souring investment sentiment. HanBio, Frontier and InnoCare have all seen their fundraising efforts hampered to various degrees.

China Financing

Finance Watch: VC Mega-Rounds Surge Again, Led By Acelyrin’s $300m Series C

Private Company Edition: Acelyrin will use its latest funding for Phase III development of izokibep in inflammatory diseases. Also, ArsenalBio raised $220m to take its programmable cell therapies into the clinic and RayzeBio’s $160m series D round will fund clinical trials for its radiopharmaceuticals. 

Financing Innovation

Investor Eye: Deerfield Management On Fund Building, Philanthropy, And Optimism For The Future

Andrew ElBardissi, partner on Deerfield Management’s medical technologies team, spoke to Medtech Insight about the fund’s investment strategy, the changing face of medtech, and how investment in the life sciences sector will continue to change post-COVID.

Financing Deals
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Alamo Pharmaceuticals, LLC
    • Astex Pharmaceuticals, Inc.
    • Avanir Pharmaceuticals, Inc.
    • Daiya Foods Inc.
    • Diatranz Otsuka Limited
    • JIMRO Co., Ltd.
    • Korea Otsuka Pharmaceutical Co., Ltd.
    • Mitsui & Co., Ltd
    • Montigen Pharmaceuticals
    • Neurovance, Inc.
    • Otsuka Australia Pharmaceutical Pty Ltd
    • Otsuka Pharmaceutical Factory, Inc.
    • Otsuka Medical Devices Co., Ltd.
    • Otsuka Pharmaceutical Co., Ltd
    • Otsuka Pharmaceutical India Private Limited
    • ReCor Medical, Inc.
    • Singapore Otsuka Pharmaceutical Co., Ltd.
    • SuperGen, Inc.
    • Taiwan Otsuka Pharmaceutical Co., Ltd.
    • Taiho Pharmaceutical Co., Ltd.
    • Taiho Pharma Canada, Inc.
    • Visterra Inc.
UsernamePublicRestriction

Register